Literature DB >> 34483551

Bacterial DNA screening to characterize surgical site infection risk in orthopaedic patients.

Preston N Wolfe1,2, Brian D Campfield3, Brett D Crist1,2, James A Keeney1,2, Matthew J Smith1,2, James L Cook1,2, Aaron M Stoker1,2.   

Abstract

PURPOSE: To provide an initial characterization of relevant bacterial DNA profiles for patients undergoing closed-fracture fixation or total joint arthroplasties. PATIENTS AND METHODS: Swabs were collected and analyzed using Polymerase Chain Reaction from adult patients undergoing closed-fracture fixation or total shoulder, knee, or hip arthroplasties.
RESULTS: Bacterial DNA profiles varied across the different orthopaedic patient populations, and produced uncharacteristic profile shifts with direct relevance to each clinical infection.
CONCLUSION: Findings provide a foundational dataset regarding bacterial colonization of relevant anatomic sites that can act as sources of surgical site infections for patients.
© 2021 Professor P K Surendran Memorial Education Foundation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arthroplasty; Bacteria; DNA; Fractures; Polymerase chain reaction; Surgical site infection

Year:  2021        PMID: 34483551      PMCID: PMC8403679          DOI: 10.1016/j.jor.2021.08.012

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  37 in total

1.  Histological and microbiological findings in non-infected and infected revision arthroplasty tissues. The OSIRIS Collaborative Study Group. Oxford Skeletal Infection Research and Intervention Service.

Authors:  R Pandey; A R Berendt; N A Athanasou
Journal:  Arch Orthop Trauma Surg       Date:  2000       Impact factor: 3.067

2.  Prior use of antimicrobial therapy is a risk factor for culture-negative prosthetic joint infection.

Authors:  Davud Malekzadeh; Douglas R Osmon; Brian D Lahr; Arlen D Hanssen; Elie F Berbari
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

3.  Poor predictive value of broad-range PCR for the detection of arthroplasty infection in 92 cases.

Authors:  Konstantinos Panousis; Peter Grigoris; Ian Butcher; Bardeep Rana; James H Reilly; David L Hamblen
Journal:  Acta Orthop       Date:  2005-06       Impact factor: 3.717

4.  Broad-range PCR in selected episodes of prosthetic joint infection.

Authors:  F H R De Man; P Graber; M Lüem; W Zimmerli; P E Ochsner; P Sendi
Journal:  Infection       Date:  2009-04-23       Impact factor: 3.553

5.  PCR-based diagnosis of prosthetic joint infection.

Authors:  Xinhua Qu; Zanjing Zhai; Huiwu Li; Haowei Li; Xuqiang Liu; Zhenan Zhu; You Wang; Guangwang Liu; Kerong Dai
Journal:  J Clin Microbiol       Date:  2013-06-05       Impact factor: 5.948

6.  Chronic surgical site infection due to suture-associated polymicrobial biofilm.

Authors:  Sandeep Kathju; Laura Nistico; Luanne Hall-Stoodley; J Christopher Post; Garth D Ehrlich; Paul Stoodley
Journal:  Surg Infect (Larchmt)       Date:  2009-10       Impact factor: 2.150

7.  Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media.

Authors:  Luanne Hall-Stoodley; Fen Ze Hu; Armin Gieseke; Laura Nistico; Duc Nguyen; Jay Hayes; Michael Forbes; David P Greenberg; Bethany Dice; Amy Burrows; P Ashley Wackym; Paul Stoodley; J Christopher Post; Garth D Ehrlich; Joseph E Kerschner
Journal:  JAMA       Date:  2006-07-12       Impact factor: 56.272

Review 8.  Patient-specific risk factors for infection in arthroplasty procedure.

Authors:  S Marmor; Y Kerroumi
Journal:  Orthop Traumatol Surg Res       Date:  2016-01-19       Impact factor: 2.256

9.  Periprosthetic joint infections treated with two-stage revision over 14 years: an evolving microbiology profile.

Authors:  Benjamin T Bjerke-Kroll; Alexander B Christ; Alexander S McLawhorn; Peter K Sculco; Kethy M Jules-Elysée; Thomas P Sculco
Journal:  J Arthroplasty       Date:  2013-10-04       Impact factor: 4.757

10.  Culture and PCR analysis of joint fluid in the diagnosis of prosthetic joint infection.

Authors:  Jiri Gallo; Milan Kolar; Milos Dendis; Yvona Loveckova; Pavel Sauer; Jana Zapletalova; Dagmar Koukalova
Journal:  New Microbiol       Date:  2008-01       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.